Variation in transcriptional regulation of cyclin dependent kinase inhibitor p21waf1/cip1 among human bronchogenic carcinomas

Table 2 Transcript abundance measurements for primary normal BEC and BC tissues

Sample ID	Diagnosis	Cell Type	E2F1	p73α	p21
63	NC	N	270	850	14,000
282	NC	N	540	640	10,000
64	NC	N	2,000	400	10,000
285	NC	N	2,500	870	3,100
257	NC	N	270	5,200	12,000
156	NC	N	750	1,000	25,000
194	NC	N	290	3,800	3,500
150	NC	N	160	3,700	11,000
136	NC	N	700	31	9,100
261	NC	N	250	3,100	30,000
191	C	N	150	900	13,000
158	C	N	190	2,200	11,000
146	C	N	230	2,600	9,100
34	C	N	570	4,400	12,000
212	C	N	600	5,300	35,000
274	C	Sq	730	1	7,000
279	C	A	1,200	1	4,000
190	C	BA	6,600	3	27,000
102	C	A	12,000	21	21,000
165	C	SC	36,000	4,300	16,000
123	C	Sq	54,000	5,500*	90,000
277*	C	A	120,000	100	2,000

NC, non-cancer; C, cancer; N, normal; Sq, squamous carcinoma; A, adenocarcinoma; BA, bronchoalveolar carcinoma; SC, small cell carcinoma. Non-detectable TA were entered as 1 to allow plotting on a logarithmic scale. Normal BEC are grouped by diagnosis and cell type. BC tissues are grouped by increasing E2F1 TA. All values are in units of molecules/10⁶ molecules β-actin and represent the mean from three independent measurements. *This value represents the mean from two measurements due to insufficient sample.

ISSN: 1476-4598